6/25/2025

The United States market has experienced a positive trend, climbing 1.9% in the last week and showing a 12% increase over the past year, with earnings projected to grow by 14% annually. In this environment, growth companies with high insider ownership can be particularly appealing as they often signal confidence from those closest to the business operations and strategy.

Source: Yahoo

6/22/2025

NEW YORK, June 22, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, Inc. . Such investors are advised to contact Danielle Peyton...

Source: Finnhub

6/18/2025

Shareholders of Globus Medical would probably like to forget the past six months even happened. The stock dropped 28.9% and now trades at $58.14. This was partly due to its softer quarterly results and might have investors contemplating their next move.

Source: Yahoo

6/13/2025

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Source: Yahoo

6/12/2025

Looking back on medical devices & supplies - specialty stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Globus Medical (NYSE:GMED) and its peers.

Source: Yahoo

6/10/2025

Medical device company Globus Medical (NYSE:GMED) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 1.4% year on year to $598.1 million. On the other hand, the company’s full-year revenue guidance of $2.85 billion at the midpoint came in 4.2% above analysts’ estimates. Its non-GAAP profit of $0.68 per share was 8.6% below analysts’ consensus estimates.

Source: Yahoo

6/6/2025

Growth is oxygen. But when it evaporates, the consequences can be extreme - ask anyone who bought Cisco in the Dot-Com Bubble (Nvidia?) or newer investors who lived through the 2020 to 2022 COVID cycle.

Source: Yahoo

6/5/2025

ISRG's da Vinci 5 is gaining momentum with key innovations like Force Feedback and strong Q1 placements boosting adoption.

Source: Yahoo

6/2/2025

Source: Fintel

5/27/2025

On Tuesday, May 27, an analyst from BTIG downgraded Globus Medical Inc. (NYSE:GMED) from Buy to Neutral, citing concerns about its Spine business. The analyst did not assign a price target following the downgrade. Globus Medical is a medical device company specializing in healthcare solutions primarily for musculoskeletal disorders. In early May, the company reported […]

Source: Yahoo

5/27/2025

Source: Fintel

5/19/2025

The United States market has experienced a positive trend, rising 2.9% over the last week and 12% over the past year, with earnings projected to grow by 14% annually in the coming years. In this environment, companies like Globus Medical that exhibit strong growth potential and high insider ownership can be particularly appealing as they suggest confidence from those closest to the business.

Source: Yahoo

5/16/2025

Investors were underwhelmed by the solid earnings posted by Globus Medical, Inc. ( NYSE:GMED ) recently. Our analysis...

Source: Yahoo

5/16/2025

Looking back on medical devices & supplies - specialty stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Enovis (NYSE:ENOV) and its peers.

Source: Yahoo

5/15/2025

AUDUBON, Pa., May 15, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced that its Board of Directors has authorized a share repurchase program of up to $500 million of the Company’s outstanding common stock. “We believe the recent volatility in our share price has created a meaningful disconnect between our intrinsic value and our market valuation,” said Keith Pfeil, Chief Financial Officer and Chief Operating Officer of Globu

Source: Yahoo

5/12/2025

A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides agreed to pause some tariffs for 90 days, signaling a potential turning point in ongoing tensions. This rollback cuts U.S. tariffs on Chinese goods to 30% and Chinese tariffs on U.S. imports to 10%, giving companies breathing room to reset inventories and supply chains.

Source: Yahoo

5/12/2025

GMED's first-quarter 2025 weak performance reflects soft Enabling Technology deal closures.

Source: Yahoo

5/11/2025

Globus Medical, Inc. ( NYSE:GMED ) just released its latest quarterly report and things are not looking great. It...

Source: Yahoo

5/9/2025

Q1 2025 Globus Medical Inc Earnings Call

Source: Yahoo

5/9/2025

Despite revenue challenges, Globus Medical Inc (GMED) reports significant free cash flow growth and strategic acquisitions to bolster future performance.

Source: Yahoo